These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7856330)

  • 21. Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats.
    Southam E; Kirkby D; Higgins GA; Hagan RM
    Eur J Pharmacol; 1998 Sep; 358(1):19-24. PubMed ID: 9809864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in learning and memory, acetylcholinesterase activity and monoamines in brain after chronic carbamazepine administration in rats.
    Sudha S; Lakshmana MK; Pradhan N
    Epilepsia; 1995 Apr; 36(4):416-22. PubMed ID: 7607122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of non-toxic and toxic concentrations of phenytoin on monoamines levels in rat brain.
    Okada M; Kawata Y; Kiryu K; Mizuno K; Wada K; Inomata H; Tasaki H; Kaneko S
    Epilepsy Res; 1997 Sep; 28(2):155-63. PubMed ID: 9267780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the new potential anti-Parkinson agent, hymantane, on levels of monoamines and their metabolites in rat striatum (a microdialysis study)].
    Andiarzhanova EA; Val'dman EA; Kudrin VS; Raevskiĭ KS; Voronina TA
    Eksp Klin Farmakol; 2001; 64(6):13-6. PubMed ID: 11871228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nefiracetam (DM-9384), a pyrrolidone derivative, on brain monoamine systems.
    Luthman J; Lindqvist E; Kojima H; Shiotani T; Tanaka M; Tachizawa H; Olson L
    Arch Int Pharmacodyn Ther; 1994; 328(2):125-44. PubMed ID: 7535993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of combined administration of zonisamide and valproic acid or phenytoin to nitric oxide production, monoamines and zonisamide concentrations in the brain of seizure-susceptible EL mice.
    Nagatomo I; Akasaki Y; Uchida M; Tominaga M; Hashiguchi W; Takigawa M
    Brain Res Bull; 2000 Sep; 53(2):211-8. PubMed ID: 11044598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
    Murata M
    Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus.
    De La Garza R; Asnis GM
    Brain Res; 2003 Jul; 977(1):70-9. PubMed ID: 12788515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacology of the novel antiepileptic compound zonisamide. 1st communication: effects on central nervous system.
    Hori M; Ito T; Oka M; Noda Y; Matsuno Y; Furukawa K; Ochi Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1124-30. PubMed ID: 3435583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.
    Nakatsuji K; Matsuno Y; Nakamura N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1987 Oct; 37(10):1131-6. PubMed ID: 3435584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of antiparkinsonian drug hemantane on the level and metabolism of biogenic monoamines in brain structures of C57BL/6 mice].
    Abaimov DA; Zimin IA; Kudrin VS; Kovalev GI
    Eksp Klin Farmakol; 2009; 72(1):64-7. PubMed ID: 19334515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 3,N,N'-trimethyl-2-phenyl-1,4-piperazine diastereomers on monoamine uptake and monoamine oxidase in rat brain.
    Smith DF; Jensen PN; Gelbcke M; Tytgat D
    J Neural Transm Gen Sect; 1992; 88(3):177-85. PubMed ID: 1418859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isatin: possible role in functional interaction of natriuretic peptides and monoamines].
    Glover V; Medvedev AE; Sandler M
    Vopr Med Khim; 1997; 43(6):515-21. PubMed ID: 9503568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.
    Thiblin I; Finn A; Ross SB; Stenfors C
    Br J Pharmacol; 1999 Mar; 126(6):1301-6. PubMed ID: 10217522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of nitric oxide and monoamines in the brain of the EL mouse treated with phenobarbital and zonisamide.
    Tominaga M; Nagatomo I; Uchida M; Hashiguchi W; Akasaki Y; Takigawa M
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):311-8. PubMed ID: 11442880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.